Type I And III IFN Expression Attenuated In Human Alternatively Activated Macrophages

被引：0
|
作者：
El Fiky, A. [1 ]
Perreault, R. [1 ]
Rabin, R. L. [1 ]
机构：
[1] FDA CBER, Bethesda, MD USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2012年 / 129卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2011.12.373
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB163 / AB163
页数：1
相关论文
共 50 条
  • [41] Taenia crassiceps Antigens Control Experimental Type 1 Diabetes by Inducing Alternatively Activated Macrophages
    Espinoza-Jimenez, Arlett
    De Haro, Roberto
    Terrazas, Luis I.
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [42] Soluble Factors in the Murine Placenta Regulate Gene Expression in Alternatively-Activated Macrophages.
    Zhao, Hui
    Kalish, Flora
    Wong, Ronald J.
    Stevenson, David K.
    REPRODUCTIVE SCIENCES, 2019, 26 : 293A - 293A
  • [43] CAGE sequencing reveals CFTR-dependent dysregulation of type I IFN signaling in activated cystic fibrosis macrophages
    Gillan, Jonathan L.
    Chokshi, Mithil
    Hardisty, Gareth R.
    Hendry, Sara Clohisey
    Prasca-Chamorro, Daniel
    Robinson, Nicola J.
    Lasota, Benjamin
    Clark, Richard
    Murphy, Lee
    Whyte, Moira K. B.
    Baillie, J. Kenneth
    Davidson, Donald J.
    Bao, Gang
    Gray, Robert D.
    SCIENCE ADVANCES, 2023, 9 (21):
  • [44] Murine gammaherpesvirus targets type I IFN receptor but not type III IFN receptor early in infection
    Lopusna, Katarina
    Benkoczka, Timea
    Luptak, Jakub
    Matuskova, Radka
    Lukacikova, Lubomira
    Oveckova, Ingrid
    Rezuchova, Ingeborg
    CYTOKINE, 2016, 83 : 158 - 170
  • [45] Subsets of alternatively activated human macrophages show differential capacity to produce reactive oxygen species
    Kraaij, M. D.
    Koekkoek, K. M.
    van der Kooij, S. W.
    Gelderman, K. A.
    van Kooten, C.
    IMMUNOLOGY, 2012, 137 : 282 - 282
  • [46] Impacts of type I interferons (IFN-α and IFN-T) and type II interferon (IFN-γ) on the kynurenine pathway in human uninfected or HIV-1 infected macrophages(IFN-γ) on the kynurenine pathway in human uninfected or HIV-1 infected macrophages
    Manéglier, B
    Rogez-Kreuz, C
    Spreux-Varoquaux, O
    Dereuddre-Bosquet, N
    Martal, J
    Thérond, P
    Advenier, C
    Dormont, D
    Clayette, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S6 - S6
  • [47] Efferocytosis potentiates the expression of arachidonate 15-lipoxygenase (ALOX15) in alternatively activated human macrophages through LXR activation
    Ryan G. Snodgrass
    Yvonne Benatzy
    Tobias Schmid
    Dmitry Namgaladze
    Malwina Mainka
    Nils Helge Schebb
    Dieter Lütjohann
    Bernhard Brüne
    Cell Death & Differentiation, 2021, 28 : 1301 - 1316
  • [48] Efferocytosis potentiates the expression of arachidonate 15-lipoxygenase (ALOX15) in alternatively activated human macrophages through LXR activation
    Snodgrass, Ryan G.
    Benatzy, Yvonne
    Schmid, Tobias
    Namgaladze, Dmitry
    Mainka, Malwina
    Schebb, Nils Helge
    Luetjohann, Dieter
    Bruene, Bernhard
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (04): : 1301 - 1316
  • [49] Bat type I IFN: Contraction of the genetic locus and constitutive expression of IFNα
    Zhou, Peng
    Boyd, Victoria
    Tachedjian, Mary
    Cui, Jie
    Smith, Ina
    Cowled, Chris
    Wynne, James
    Wang, Linfa
    Baker, Michelle
    CYTOKINE, 2015, 76 (01) : 73 - 73
  • [50] HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling
    Chandra, Partha K.
    Bao, Lili
    Song, Kyoungsub
    Aboulnasr, Fatma M.
    Baker, Darren P.
    Shores, Nathan
    Wimley, William C.
    Liu, Shuanghu
    Hagedorn, Curt H.
    Fuchs, Serge Y.
    Wu, Tong
    Balart, Luis A.
    Dash, Srikanta
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (01): : 214 - 229
12345